Real-time enrollment status for this acute leukemia of ambiguous lineage clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 6:11 PM UTC
| NCT Number | NCT06013423 |
| Recruiting Status | Recruiting |
| Condition | Acute Leukemia of Ambiguous Lineage |
| Phase | PHASE2 |
| Target Enrollment | 54 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fred Hutchinson Cancer Center |
| Last Updated on CT.gov | January 22, 2026 (Jan 22, 2026) |
As of July 17, 2026: Clinical trial NCT06013423 is currently recruiting participants. This phase2 study for acute leukemia of ambiguous lineage is actively seeking new participants at 1 location across the United States. The study is sponsored by Fred Hutchinson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06013423 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06013423 was last updated Jan 22, 2026 (January 22, 2026). HelloStudys verifies this status automatically.